Empowering dialysis users and caregivers
Search for dialysis centres here
Log in to explore the world's most comprehensive database of dialysis centres for free!
Professional dialysis recruitment| Baxter to Initiate Second Phase III Trial Studying GAMMAGARD LIQUID (IGIV) for ... - MarketWatch (press release) |
 |
 |
|
MarketWatch (press release) Renal dysfunction, acute renal failure, osmotic nephrosis, and death may occur with immune globulin intravenous (IGIV) products in predisposed patients. Patients predisposed to renal dysfunction include those with any degree of pre-existing renal |
